lung cancer

SINGAPORE (Sept 9): Biolidics, the medical technology company, is collaborating with Hangzhou Normal University to undertake clinical investigations to validate the clinical utility of CTCs as a biomarker in late stage lung cancer.

BEIJING (Jan 6): The thick haze of pollution blanketing northern China this winter is a grim reminder of the nation’s new growth industry: lung cancer drugs.